World Antibiotic Awareness Week – November 13-19, 2017

13 November, 2017


 

bioMérieux is dedicated to providing market-leading diagnostic solutions for the prevention and management of antibiotic resistance, and to raising awareness about this major public health threat through global education initiatives.

Support World Antibiotic Awareness Week by sharing these initiatives within your facility and community.

 

 ► Visit our Antimicrobial Resistance website

 ► See what the experts have to say !

 ► Calling all hospitals to enroll in the 2017 Global-PPS !

 ► Discover our Diagnostic Solutions to curb Antimicrobial Resistance

 


Visit our Antimicrobial Resistance website

Accessible – Interactive – Educational !

www.antimicrobial-resistance.biomerieux.com

 

 


See what the experts have to say !

Dr Wang on colistin research

 

International experts speak out on key topics


Calling all hospitals to enroll in the 2017 Global-PPS !

Global Point Prevalence Survey (Global-PPS) of Hospital Antibiotic Use and Resistance

Following the success of the first survey in 2015 and thanks to bioMérieux’s continued sponsorship, the Global PPS is being repeated in 2017. 

This global initiative provides a unique overview of the burden of antibiotic consumption and resistance rates. Data is now being collected from over 65 countries worldwide.

It’s not too late ! Join the 2017 Global-PPS initiative today.

Contact global-PPS@uantwerpen.be or visit the Global PPS website

Read more about 2015 Global PPS findings


Discover our Diagnostic Solutions to curb Antimicrobial Resistance

As world leader in microbiology, bioMérieux is dedicated to helping clinical labs provide actionable results faster to help prevent and manage multi-drug resistance and improve patient outcomes.

 Read more about “Combating Antimicrobial Resistance” in the bioMérieux ID/AST newsletter

Rapid diagnostic test results provide antibiotic therapy guidance, supporting clinicians in the decision-making process. For example, procalcitonin-guided antibiotic therapy, as well as faster detection and reporting of  antibiotic-resistant infections help avoid unnecessary antibiotic treatments and secondary drug effects, prevent the emergence of new resistant strains and reduce length of hospital stay, all while improving patient outcomes.

Our high-medical value diagnostic tests enable timely detection and diagnosis of healthcare-associated and multi-drug resistant infections.

We provide clinical laboratories with a wide range of diagnostic solutions for effective screening, infection control, outbreak management and antibiotic stewardship.

 Discover our Antimicrobial Resistance Management solutions

 

Pioneering diagnostics